In addition, incorporating complementary viability and apoptosis assays, such as BrdU incorporation, annexin V/PI staining, or live/dead analysis, could provide further mechanistic detail regarding the anti-cancer effects of MSC1 cells on CRC. The gene discussed is ANXA5; the disease is colorectal carcinoma.